SI Share Price Performance
US$14.39
-0.66 (-4.39%)
30.1% undervalued intrinsic discount
US$20.60
Fair Value
Price US$14.39
AnalystConsensusTarget US$20.60
Fair ValueUS$20.60
Share Pricen/a
Shoulder Innovations, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
SI Community Narratives
AN
Fair Value US$20.6 30.1% undervalued intrinsic discount
Aging Demographics And Rising Shoulder Arthroplasty Demand Will Drive Long-Term Market Expansion
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Aging Demographics And Rising Shoulder Arthroplasty Demand Will Drive Long-Term Market Expansion
Catalysts About Shoulder Innovations Shoulder Innovations develops specialized shoulder arthroplasty implants and enabling technologies that aim to improve surgical efficiency and long term patient outcomes. What are the underlying business or industry changes driving this perspective?Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$20.6
30.1% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
30.21% p.a.
Profit Margin
12.91%
Future PE
54.87x
Price in 2028
US$14.38
Trending Discussion
Recently Updated Narratives
AN
Aging Demographics And Rising Shoulder Arthroplasty Demand Will Drive Long-Term Market Expansion
Fair Value: US$20.6 30.1% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Shoulder Innovations, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -1.77
- 76.67%
- -87.39%
- 10.0%
About SI
- Founded
- 2009
- Employees
- 56
- CEO
- WebsiteView website
Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States. It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion. The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan.
